Tag: Carillon

TCT 2018: Sham-controlled trial indicates indirect annuloplasty reduces mitral regurgitation

REDUCE-FMR indicates that indirect annuloplasty with the Carillon device (Cardiac Dimensions) is...

First patient enrolled in CARILLON pivotal trial

Cardiac Dimensions has announced the company has randomised its first patient in the CARILLON pivota...

Cardiac Dimensions appoints Matthew Stark as vice president of Clinical and Regulatory Affairs

Cardiac Dimensions has appointed Matthew Stark as vice president of clinical and regulatory affairs,...

FDA grant Cardiac Dimensions investigational device exemption approval to conduct study

Cardiac Dimensions has received FDA approval for its investigational device exemption (IDE) CARILLON...